Todd D Schell

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2023
Publications (10 Years): 8

Top Venues

Cancer research

Journal of immunology (Baltimore, Md. : 1950)

Cancer immunology, immunotherapy : CII

Oncoimmunology

Pennsylvania State University College of Medicine

West Virginia University School of Medicine (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Pennsylvania State University College of Medicine

United States

Professor :: Microbiology and Immunology

Education History

West Virginia University School of Medicine

United States

PHD :: Microbiology and Immunology

Publications

Andrea Manni, Yuan-Wan Sun, Todd D Schell, Tymofiy Lutsiv, Henry J Thompson, Kun-Ming Chen, Cesar Aliaga, Junjia Zhu, Karam El-Bayoumy
Complementarity between Microbiome and Immunity May Account for the Potentiating Effect of Quercetin on the Antitumor Action of Cyclophosphamide in a Triple-Negative Breast Cancer Model. Pharmaceuticals (Basel, Switzerland) 16 (10) (2023)
Bei Jia, Chenchen Zhao, Kentaro Minagawa, Hiroko Shike, David F Claxton, W Christopher Ehmann, Witold B Rybka, Shin Mineishi, Ming Wang, Todd D Schell, K Sandeep Prabhu, Robert F Paulson, Yi Zhang, Leonard D Shultz, Hong Zheng
Acute Myeloid Leukemia Causes T Cell Exhaustion and Depletion in a Humanized Graft-versus-Leukemia Model. Journal of immunology (Baltimore, Md. : 1950) (2023)
Pavan Kumar Dhanyamraju, Todd D Schell, Shantu Amin, Pavan Kumar Dhanyamraju
Drug-Tolerant Persister Cells in Cancer Therapy Resistance. Cancer research 82 (14) (2022)
Bei Jia, Chenchen Zhao, Kevin L Rakszawski, David F Claxton, W Christopher Ehmann, Witold B Rybka, Shin Mineishi, Ming Wang, Hiroko Shike, Michael G Bayerl, Jeffrey M Sivik, Todd D Schell, Joseph J Drabick, Raymond J Hohl, Hong Zheng
Eomes+T-betlow CD8+ T Cells Are Functionally Impaired and Are Associated with Poor Clinical Outcome in Patients with Acute Myeloid Leukemia. Cancer research 79 (7) (2019)
Kathleen M Kokolus, Jeremy S Haley, Emily J Koubek, Raghavendra Gowda, Saketh S Dinavahi, Arati Sharma, David F Claxton, Klaus F Helm, Joseph J Drabick, Gavin P Robertson, Jeffrey D Neighbors, Raymond J Hohl, Todd D Schell
Schweinfurthin natural products induce regression of murine melanoma and pair with anti-PD-1 therapy to facilitate durable tumor immunity. Oncoimmunology 8 (2) (2018)
Lindsay K Ward-Kavanagh, Kathleen M Kokolus, Timothy K Cooper, Aron E Lukacher, Todd D Schell
Combined sublethal irradiation and agonist anti-CD40 enhance donor T cell accumulation and control of autochthonous murine pancreatic tumors. Cancer immunology, immunotherapy : CII 67 (4) (2018)
Arash Memarnejadian, Courtney E Meilleur, Christopher R Shaler, Khashayarsha Khazaie, Jack R Bennink, Todd D Schell, S M Mansour Haeryfar
PD-1 Blockade Promotes Epitope Spreading in Anticancer CD8+ T Cell Responses by Preventing Fratricidal Death of Subdominant Clones To Relieve Immunodomination. Journal of immunology (Baltimore, Md. : 1950) 199 (9) (2017)
Saumya Maru, Ge Jin, Todd D Schell, Aron E Lukacher
TCR stimulation strength is inversely associated with establishment of functional brain-resident memory CD8 T cells during persistent viral infection. PLoS pathogens 13 (4) (2017)

Todd D Schell.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Todd D Schell